We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
-5.02%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$593M
AUM Growth
-$12M
Cap. Flow
+$24.6M
Cap. Flow %
4.16%
Top 10 Hldgs %
49.61%
Holding
3,046
New
350
Increased
1,337
Reduced
784
Closed
167

Sector Composition

Rank Sector Weight
1 Financials 19.66%
2 Technology 11.68%
3 Healthcare 5.39%
4 Consumer Discretionary 4.17%
5 Energy 3.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRBR icon
2001
BellRing Brands
BRBR
$1.32B
$2K ﹤0.01%
76
BRKL
2002
DELISTED
Brookline Bancorp
BRKL
$2K ﹤0.01%
157
BRT
2003
BRT Apartments
BRT
$266M
$2K ﹤0.01%
+97
New +$2.21K
BVN icon
2004
Compañía de Minas Buenaventura
BVN
$8.78B
$2K ﹤0.01%
+273
New +$1.62K
BW icon
2005
Babcock & Wilcox
BW
$1.32B
$2K ﹤0.01%
278
+9
+3% +$67
CAR icon
2006
Avis
CAR
$4.9B
$2K ﹤0.01%
16
-64
-80% -$10.5K
CASS icon
2007
Cass Information Systems
CASS
$734M
$2K ﹤0.01%
57
+22
+63% +$790
CBT icon
2008
Cabot Corp
CBT
$4.46B
$2K ﹤0.01%
30
+19
+173% +$1.34K
CBZ icon
2009
CBIZ
CBZ
$2.95B
$2K ﹤0.01%
55
+19
+53% +$831
CCB icon
2010
Coastal Financial
CCB
$743M
$2K ﹤0.01%
60
+44
+275% +$1.78K
CCRN
2011
DELISTED
Cross Country Healthcare
CCRN
$2K ﹤0.01%
83
CEF icon
2012
Sprott Physical Gold and Silver Trust
CEF
$8.3B
$2K ﹤0.01%
125
CGEM icon
2013
Cullinan Oncology
CGEM
$1.18B
$2K ﹤0.01%
178
CHE icon
2014
Chemed
CHE
$7.18B
$2K ﹤0.01%
4
-2
-33% -$962
CIVI
2015
DELISTED
Civitas Resources
CIVI
$2K ﹤0.01%
38
+15
+65% +$883
CLS icon
2016
Celestica
CLS
$39.7B
$2K ﹤0.01%
225
-230
-51% -$2.33K
CMPR icon
2017
Cimpress
CMPR
$2.3B
$2K ﹤0.01%
63
+41
+186% +$1.4K
CNOB icon
2018
Center Bancorp
CNOB
$1.77B
$2K ﹤0.01%
101
-81
-45% -$2.07K
COKE icon
2019
Coca-Cola Consolidated
COKE
$12.4B
$2K ﹤0.01%
50
-20
-29% -$984
COMP icon
2020
Compass
COMP
$9.52B
$2K ﹤0.01%
+785
New +$2.79K
CRNC icon
2021
Cerence
CRNC
$403M
$2K ﹤0.01%
100
+24
+32% +$539
CRNX icon
2022
Crinetics Pharmaceuticals
CRNX
$8.93B
$2K ﹤0.01%
113
+12
+12% +$245
CVGW
2023
DELISTED
Calavo Growers
CVGW
$2K ﹤0.01%
77
+9
+13% +$361
CWK icon
2024
Cushman & Wakefield Ltd
CWK
$3.12B
$2K ﹤0.01%
134
+63
+89% +$951
CXW icon
2025
CoreCivic
CXW
$3.26B
$2K ﹤0.01%
268
-79
-23% -$798

Similar funds

Lindbrook Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Lindbrook Capital held 3,046 positions worth $593M, down 2% from $605M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Lindbrook Capital deployed $24.6M of net new capital in Q3 2022, opening 350 new positions and adding to 1,337 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1 share worth $406K.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $1.03M trimmed.

  • Lindbrook Capital's largest Q3 2022 buy was Berkshire Hathaway Class A: 1 share worth $406K.
  • Lindbrook Capital added most to RPAR Risk Parity ETF in Q3 2022, an estimated $5.24M increase.
  • Lindbrook Capital's biggest Q3 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $1.03M.
  • Lindbrook Capital fully exited ProShares UltraShort S&P500 in Q3 2022, selling an estimated $219K.
  • Lindbrook Capital's ten largest holdings make up 50% of its $593M portfolio in Q3 2022.
  • Lindbrook Capital opened 350 new positions and closed 167 in Q3 2022.
  • Lindbrook Capital's portfolio value fell 2% quarter-over-quarter to $593M.

Based on Lindbrook Capital's 13F filing for Q3 2022, filed 10 Nov 2022.